A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants

NCT06262477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: BIIB800
DRUG: Actemra

Sponsor

Biogen